M. Rehan

Computational Insights into 1,4-Naphthoquinones as Allosteric MEK1 Inhibitors for Cancer Therapy.

Early enrichment of true positives over decoys strongly supports the screening protocol, and common key residues shared between the naphthoquinones and the native inhibitor suggest a similar inhibitory mechanism.